AU2002242705A1 - Utilization of buprenorphine in urinary incontinence therapy - Google Patents
Utilization of buprenorphine in urinary incontinence therapyInfo
- Publication number
- AU2002242705A1 AU2002242705A1 AU2002242705A AU2002242705A AU2002242705A1 AU 2002242705 A1 AU2002242705 A1 AU 2002242705A1 AU 2002242705 A AU2002242705 A AU 2002242705A AU 2002242705 A AU2002242705 A AU 2002242705A AU 2002242705 A1 AU2002242705 A1 AU 2002242705A1
- Authority
- AU
- Australia
- Prior art keywords
- buprenorphine
- utilization
- urinary incontinence
- incontinence therapy
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010046543 Urinary incontinence Diseases 0.000 title 1
- RMRJXGBAOAMLHD-CTAPUXPBSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-CTAPUXPBSA-N 0.000 title 1
- 229960001736 buprenorphine Drugs 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10107828.5 | 2001-02-16 | ||
DE2001107828 DE10107828A1 (en) | 2001-02-16 | 2001-02-16 | Use of buprenorphin for treating urinary incontinence and related conditions, at below analgesic levels, particularly delivered from skin patches |
DE20115429.3 | 2001-09-18 | ||
DE20115429U DE20115429U1 (en) | 2001-09-18 | 2001-09-18 | Opioids in urinary incontinence |
DE10162704.1 | 2001-12-19 | ||
DE2001162704 DE10162704A1 (en) | 2001-12-19 | 2001-12-19 | Use of buprenorphin for treating urinary incontinence and related conditions, at below analgesic levels, particularly delivered from skin patches |
PCT/EP2002/001699 WO2002066031A1 (en) | 2001-02-16 | 2002-02-18 | Utilization of buprenorphine in urinary incontinence therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002242705A1 true AU2002242705A1 (en) | 2003-02-27 |
AU2002242705B2 AU2002242705B2 (en) | 2006-08-24 |
Family
ID=27214302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002242705A Ceased AU2002242705B2 (en) | 2001-02-16 | 2002-02-18 | Utilization of buprenorphine in urinary incontinence therapy |
Country Status (14)
Country | Link |
---|---|
US (1) | US20040102468A1 (en) |
EP (1) | EP1368023B1 (en) |
JP (1) | JP4908726B2 (en) |
AT (1) | ATE314066T1 (en) |
AU (1) | AU2002242705B2 (en) |
CA (1) | CA2438339C (en) |
DE (1) | DE50205438D1 (en) |
DK (1) | DK1368023T3 (en) |
ES (1) | ES2255607T3 (en) |
HU (1) | HU229354B1 (en) |
MX (1) | MXPA03006742A (en) |
NZ (1) | NZ528064A (en) |
PL (1) | PL204638B1 (en) |
WO (1) | WO2002066031A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1323421A1 (en) * | 2001-12-20 | 2003-07-02 | Grünenthal GmbH | Use of buprenorphine for the manufacture of a transdermal delivery device for the treatment of urinary incontinence, especially urge incontinence |
US8260389B2 (en) | 2003-10-15 | 2012-09-04 | Hegln (Dalian) Pharmaceuticals, Inc. | Bladder function monitoring methods, apparatuses, media and signals |
WO2005034754A1 (en) | 2003-10-15 | 2005-04-21 | The University Of British Columbia | Methods and apparatus for urodynamic analysis |
US11547676B2 (en) * | 2012-12-28 | 2023-01-10 | Teikoku Seiyaku Co., Ltd. | Extended buprenorphine transdermal delivery compositions and methods for using the same |
EP3067357A1 (en) | 2015-03-11 | 2016-09-14 | Siegfried AG | Method of manufacturing stereoisomers of buprenorphine and analogues thereof |
CN107320770A (en) * | 2017-07-12 | 2017-11-07 | 江苏西宏生物医药有限公司 | One kind injection implant |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5486362A (en) * | 1991-05-07 | 1996-01-23 | Dynagen, Inc. | Controlled, sustained release delivery system for treating drug dependency |
DE4446600A1 (en) * | 1994-12-24 | 1996-06-27 | Lohmann Therapie Syst Lts | Transdermal absorption of active ingredients from supercooled melts |
EP0820288B1 (en) * | 1995-03-03 | 2004-02-11 | Endo Pharmaceuticals Inc. | Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence |
JPH1036265A (en) * | 1996-07-19 | 1998-02-10 | Nitto Denko Corp | Buprenorphine percutaneous absorption preparation |
US5968547A (en) * | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
US5900420A (en) * | 1997-06-19 | 1999-05-04 | Cole; William L. | Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine |
IT1302682B1 (en) * | 1998-10-16 | 2000-09-29 | Formenti Farmaceutici Spa | ORAL PHARMACEUTICAL COMPOSITIONS CONTAINING BUPRENORPHINE |
-
2002
- 2002-02-18 EP EP02708327A patent/EP1368023B1/en not_active Expired - Lifetime
- 2002-02-18 WO PCT/EP2002/001699 patent/WO2002066031A1/en active IP Right Grant
- 2002-02-18 DK DK02708327T patent/DK1368023T3/en active
- 2002-02-18 ES ES02708327T patent/ES2255607T3/en not_active Expired - Lifetime
- 2002-02-18 NZ NZ528064A patent/NZ528064A/en not_active IP Right Cessation
- 2002-02-18 JP JP2002565589A patent/JP4908726B2/en not_active Expired - Fee Related
- 2002-02-18 AT AT02708327T patent/ATE314066T1/en active
- 2002-02-18 HU HU0302984A patent/HU229354B1/en not_active IP Right Cessation
- 2002-02-18 AU AU2002242705A patent/AU2002242705B2/en not_active Ceased
- 2002-02-18 CA CA2438339A patent/CA2438339C/en not_active Expired - Fee Related
- 2002-02-18 MX MXPA03006742A patent/MXPA03006742A/en active IP Right Grant
- 2002-02-18 PL PL367401A patent/PL204638B1/en unknown
- 2002-02-18 DE DE50205438T patent/DE50205438D1/en not_active Expired - Lifetime
-
2003
- 2003-08-15 US US10/641,296 patent/US20040102468A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001275257A1 (en) | Methods and devices for the treatment of urinary incontinence | |
AU2003252067A1 (en) | Apparatus and methods for treating female urinary incontinence | |
AU2003218123A1 (en) | Shaped tampon | |
AU2002315166A1 (en) | Sir2alpha-based therapeutic and prophylactic methods | |
AU2003296883A1 (en) | Apparatus and methods for treating female urinary incontinence | |
AU2002231206A1 (en) | Treatment of depression | |
AUPR074500A0 (en) | Treatment of t cell disorders | |
AU2003240717A1 (en) | Combination of selected opioids with other active substances for use in the therapy of urinary incontinence | |
AUPQ968700A0 (en) | Treatment of urinary incontinence | |
AU2002242705A1 (en) | Utilization of buprenorphine in urinary incontinence therapy | |
AU2002233210A1 (en) | Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence | |
AU2002227247A1 (en) | Biofilm therapy process and elements | |
HUP0302984A3 (en) | Utilization of buprenorphine for preparation of pharmaceutical composition useful in urinary incontinence therapy | |
AU2002233209A1 (en) | Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence | |
AU2001261324A1 (en) | Psoriasis treatment | |
AU1196601A (en) | Methods of diagnosing and treating urinary incontinence | |
SI1368023T1 (en) | Utilization of buprenorphine in urinary incontinence therapy | |
AU2003280137A1 (en) | The use of 4-phenyl-substituted tetrahydroisoquinolines in the treatment of pain, migraine headaches and urinary incontinence | |
AU6686700A (en) | Treatment of urinary incontinence | |
AU2001253560A1 (en) | Methods of treatment | |
AU2002304453A1 (en) | Preparation and use of amorphous lisinopril | |
AU2003281205A1 (en) | Remedy for urinary frequency and urinary incontinence | |
AU2001266665A1 (en) | Process for propagation and utilization of mimosa | |
AU2003211908A1 (en) | Therapeutic agent for urinary incontinence | |
AU2002250088A1 (en) | Devices and methods for treatment of incontinence |